Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12903289 | 0.73 | — | — | |
| SCHEMBL189762 | 0.65 | LMNA (0.44) | — | |
| SCHEMBL18229312 | 0.64 | — | — | |
| SCHEMBL26754309 | 0.64 | ALDH1A1 (0.41) | — | |
| SCHEMBL1346216 | 0.64 | CHRM2 (0.43) | GAA | |
| SCHEMBL2375033 | 0.63 | PIK3CD (0.30) | — | |
| SCHEMBL15095415 | 0.63 | ALDH1A1 (0.39) | — | |
| SCHEMBL16399328 | 0.63 | — | — | |
| SCHEMBL28162736 | 0.63 | LTA4H (0.33) | GAA | |
| SCHEMBL12527389 | 0.62 | BTK (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140200198-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2014-07-17 | — | — | US | disclosed |
| US-20090287000-A1 | LOW PRESSURE CARBONYLATION OF HETEROCYCLES | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090287000-A1 | LOW PRESSURE CARBONYLATION OF HETEROCYCLES | CBR1, CYCS, PTGIS | GAA 4771/4885 |
| US-20140200198-A1 | BORON-CONTAINING SMALL MOLECULES | BTD, BCL6B, BBOX1 | GAA 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.